AFZAL PHARMA LTD
Opportunity 54/100 (worth a look), bankability 45/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: File overdue accounts. Clears statutory overdue flag — immediate bankability uplift for refinance conversations. Most likely exit: share sale to pe / searcher (38/100). Current lenders should be on monthly review.
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Mixed signal. Worth opening the full target workup before deciding to pursue.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-06-30 | 2023-06-30 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 dissolution
- • 1 dissolution
- • 1 gazette
- • 1 dissolution
- • 1 gazette
Corporate timeline (18 events)Click to expand
- 2026-06-17📄dissolved-compulsory-strike-off-suspendeddissolution · DISS16(SOAS)
- 2026-05-26📄gazette-notice-compulsorygazette · GAZ1
- 2025-03-31📄accounts-with-accounts-type-dormantaccounts · AA
- 2024-05-16📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-04-01📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-03-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-08-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-03-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-04-22📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2019-04-22📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2019-04-13📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-03-18📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-03-18📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2016-06-22📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2016-03-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2015-08-02📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-06-17🏢Company incorporatedAs AFZAL PHARMA LTD
- 2014-06-17➕AFZAL, Zahara appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder name in company name: Company name contains director surname "AFZAL" — strong identity link between founder and business.
- +No director turnover: Company is 12 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 12 years.
Red flags
2 high ·Statutory accounts have not been filed by their due date. Can indicate admin breakdown, cash preservation, or deliberate delay.
Evidence: Next due: 2026-03-31
Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.
Evidence: Next due: 2026-07-01
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Miss Zahara Afzal Individual · British · DOB 01/1988 · age 38 | 75–100% | — | 75-100% shares | 17/06/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Manufacturing · CV postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A JHUTTI LTD→ 12232349 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| A.K OFFICE INSTALLATION LTD→ 10582041 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| A.K.F. TOOLING AND MOULDS LIMITED→ 03372360 · est 1997 · no financials extracted | — | — | — | — | 28y | — | — |
| ACTIVE VIRTUE LTD→ 15129555 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ADRENALINE ERT LIMITED→ 10588855 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| AED CARPENTRY & JOINERY LTD→ 17017855 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AELDQ LIMITED→ 04525814 · est 2002 · no financials extracted | — | — | — | — | 23y | — | — |
| AEROS MAINTENANCE LIMITED→ 03320874 · est 1997 · no financials extracted | — | — | — | — | 29y | — | — |
| AFRITEC UK LIMITED→ 09139870 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| AGCO LIMITED→ 00509133 · est 1952 · no financials extracted | — | — | — | — | 73y | — | — |
| AGGSERVE LTD→ 12466616 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| AGILITUM LTD.→ 10656216 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
10 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.